COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not stated	2026-03-06		NCT07455097

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Erasmus Medical Center	271
European Association of Urology Research Foundation	9
Fortis Hospital, India	1
Heinrich-Heine University, Duesseldorf	71
KU Leuven	110
Ludwig-Maximilians - University of Munich	67
Lund University Hospital	32
Marienhospital Herne	3
Medical University of Vienna	195
San Raffaele University Hospital, Italy	23
University Hospital, Paris	5
University of Bern	126
Universität Tübingen	12

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fortis Hospital	Kolkata	India	1
KU Leuven	Leuven	Belgium	8
Ludwig-Maximilians-University Munich	Munich	Germany	1
Lund University Hospital	Lund	Sweden	13
Marienhospital Herne	Herne	Germany	3
Medical University Vienna	Vienna	Austria	11
San Raffaele University Hospital Milan	Milan	Italy	1
University Hospital Bern	Bern	Switzerland	9
University Hospital Düsseldorf	Düsseldorf	Germany	8
University Hospital Tübingen	Tübingen	Germany	12